Published in Women's Health Weekly, December 25th, 2008
"For 6 months, 26 women with PCOS received either MET or ROSI. Blood samples for assessment of androgens, lipids and high-sensitive C-reactive protein were taken at baseline and at endpoint. Endothelium-dependent flow-mediated dilation (FMD) and glyceryl trinitrate-induced endothelium-independent dilation of brachial artery were studied before and after treatment....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly